المؤلفون: Uwe Pleyer, Salem Al-Mutairi, Conor Murphy, Rola Hamam, Shereen Hammad, Orsolya Nagy, Zsuzsanna Szepessy, Yan Guex-Crosier, Karina Julian, Zohar Habot-Wilner, Sofia Androudi

مصطلحات موضوعية: Ophthalmology, Finance, inflammation, non-infectious intermediate, posterior, or panuveitis (NIIPPU), active NIIPPU, adalimumab, anterior chamber (AC, vitreous haze (VH), chorioretinal lesions, quality of life, economic burden, HOPE study

Relation: 10779/rcsi.24961017.v1; https://figshare.com/articles/journal_contribution/Impact_of_adalimumab_in_patients_with_active_noninfectious_intermediate_posterior_and_panuveitis_in_real-life_clinical_practice_HOPE_study/24961017

الاتاحة: https://figshare.com/articles/journal_contribution/Impact_of_adalimumab_in_patients_with_active_noninfectious_intermediate_posterior_and_panuveitis_in_real-life_clinical_practice_HOPE_study/24961017